Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Sales/Fixed Asset

    Back to All Ratios
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Sales/Fixed Asset History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Sales/Fixed Asset(x) 1.421.571.261.020.93

What is the latest Sales/Fixed Asset ratio of BAFNA PHARMACEUTICALS ?

The latest Sales/Fixed Asset ratio of BAFNA PHARMACEUTICALS is 1.42 based on Mar2025 Standalone results.
Year Sales/Fixed Asset
Mar20251.42
Mar20241.57
Mar20231.26
Mar20221.02
Mar20210.93

How is Sales/Fixed Asset of BAFNA PHARMACEUTICALS Trending?

Years Sales/Fixed Asset % Change
Mar2025 1.42
-9.55
Mar2024 1.57
24.60
Mar2023 1.26
23.53
Mar2022 1.02
9.68
Mar2021 0.93 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Sales/Fixed Asset ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹284.2 Cr 4.3% -20.5% 42.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,847.0 Cr 6.8% -1.5% -2.4% Stock Analytics
DIVIS LABORATORIES ₹160,745.0 Cr 0% -4.8% 8.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,346.0 Cr 1.7% 4.1% 20.5% Stock Analytics
CIPLA ₹107,075.0 Cr 0.1% -12.8% -9.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,507.0 Cr 1.8% -0.7% 3.4% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

4.3%

-20.5%

42.8%

SENSEX

1.5%

-2.3%

9.5%


You may also like the below Video Courses